{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T02:14:16Z","timestamp":1772331256848,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Familial Mediterranean fever (FMF) is an autosomal recessive disease associated with mutations in the Mediterranean fever gene (MEFV) that manifests with recurrent episodes of febrile serositis. Fabry\u2019s disease (FD) is an X-linked lysosomal storage disease caused by mutations in the<jats:italic>alpha-galactosidase A<\/jats:italic>gene and presents with a wide range of gastrointestinal, skin, vascular, renal and neurological manifestations. FMF and FD share similar manifestations, which may lead to misdiagnosis of one as the other; mostly FD is misdiagnosed as FMF. Moreover, various overlapping manifestations may stem from comorbidities, commonly coupled to FMF (such as Behcet's disease, inflammatory bowel disease, glomerulonephritis, fibromyalgia, and multiple sclerosis), as well as from colchicine adverse effects, which may add to the diagnostic confusion. Thus, we postulated that screening FMF for FD will lead to the identification of patients falsely diagnosed with FMF or who, in addition to FMF, suffer from FD that was previously missed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To identify missed FD among the FMF population, we performed chemical and genetic analyses for FD in blood samples obtained from a cohort of FMF patients followed in the specialized FMF center of our institution. To increase the likelihood of detecting patients with FD, we enriched the surveyed FMF population with patients exhibiting manifestations shared by patients with FD or who deviate from the typical FMF presentation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and conclusions<\/jats:title><jats:p>Of 172 surveyed FMF patients in a cohort derived from a clinic dedicated to FMF, none had FD. Thus, the postulation of increased odds for detecting FD in patients with FMF was not confirmed. Further exploration for FD in FMF population, is nevertheless recommended.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40001-022-00846-1","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T09:02:37Z","timestamp":1666342957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening for Fabry\u2019s disease in a high-risk subpopulation of FMF"],"prefix":"10.1186","volume":"27","author":[{"given":"Tomer","family":"Maller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Livneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"846_CR1","first-page":"318","volume":"65","author":"M Lidar","year":"2007","unstructured":"Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65:318\u201324.","journal-title":"Neth J Med"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"The International FMF Consortium","year":"1997","unstructured":"The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797\u2013807.","journal-title":"Cell"},{"key":"846_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ni.3457","volume":"17","author":"YH Park","year":"2016","unstructured":"Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016;17:914\u201321.","journal-title":"Nat Immunol"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/berh.2000.0089","volume":"14","author":"A Livneh","year":"2000","unstructured":"Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:477\u201398.","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"846_CR5","first-page":"185","volume":"30","author":"S Padeh","year":"2003","unstructured":"Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P, Pras M, et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol. 2003;30:185\u201390.","journal-title":"J Rheumatol"},{"key":"846_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0252-7","author":"I Ben-Zvi","year":"2015","unstructured":"Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. 2015. https:\/\/doi.org\/10.1186\/s13023-015-0252-7.","journal-title":"Orphanet J Rare Dis"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/art.24570","volume":"60","author":"D Marek-Yagel","year":"2009","unstructured":"Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, et al. Clinical disease among patients heterozygous for Familial Mediterranean fever. Arthritis Rheum. 2009;60:1862\u20136.","journal-title":"Arthritis Rheum"},{"key":"846_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-14615-7_4","volume-title":"Familial Mediterranean fever","author":"I Ben-Zvi","year":"2015","unstructured":"Ben-Zvi I, Lidar M, Giat E, Kukuy O, Zafrir Y, Grossman C, et al. Clinical picture in adulthood and peculiar clinical features of FMF. In: Gattorno M, editor.\u00a0 Familial Mediterranean fever. Cham: Springer; 2015. p. 47\u201380."},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1111\/j.1572-0241.2003.08784.x","volume":"98","author":"A Mor","year":"2003","unstructured":"Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol. 2003;98:2594\u2013604.","journal-title":"Am J Gastroenterol"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.berh.2012.01.004","volume":"26","author":"O Feld","year":"2012","unstructured":"Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience. Best Pract Res Clin Rheumatol. 2012;26:119\u201333.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3899\/jrheum.130520","volume":"40","author":"O Kukuy","year":"2013","unstructured":"Kukuy O, Livneh A, Ben-David A, Kopolovic J, Volkov A, Shinar Y, et al. Familial Mediterranean fever (FMF) with proteinuria: clinical features, histology, predictors, and prognosis in a cohort of 25 patients. J Rheumatol. 2013;40:2083\u20137.","journal-title":"J Rheumatol"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1002\/art.38797","volume":"66","author":"I Eshed","year":"2014","unstructured":"Eshed I, Rosman Y, Livneh A, Kedem R, Langevitz P, Ben-Zvi I, et al. Exertional leg pain in familial Mediterranean fever: a manifestation of an underlying enthesopathy and a marker of more severe disease. Arthritis Rheumatol. 2014;66:3221\u20136.","journal-title":"Arthritis Rheumatol"},{"key":"846_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30","author":"DP Germain","year":"2010","unstructured":"Germain DP. Fabry disease. Orphanet J Rare Dis. 2010. https:\/\/doi.org\/10.1186\/1750-1172-5-30.","journal-title":"Orphanet J Rare Dis"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejim.2016.03.015","volume":"32","author":"E Verrecchia","year":"2016","unstructured":"Verrecchia E, Zampetti A, Antuzzi D, Ricci R, Ferri L, Morrone A, et al. The impact of fever\/hyperthermia in the diagnosis of Fabry: a retrospective analysis. Eur J Intern Med. 2016;32:26\u201330.","journal-title":"Eur J Intern Med"},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","volume":"64","author":"RJ Hopkin","year":"2008","unstructured":"Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain DP, et al. Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res. 2008;64:550\u20135.","journal-title":"Pediatr Res"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase a activity and genetic mutations on clinical course. Medicine (Baltimore). 2002;81:122\u201338.","journal-title":"Medicine (Baltimore)"},{"key":"846_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Anderson-fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38:750\u201360.","journal-title":"J Med Genet"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtl\u00e4nder T, Auinger M, et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol. 2004;15:1323\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gene.2013.05.050","volume":"527","author":"I Okur","year":"2013","unstructured":"Okur I, Ezgu F, Biberoglu G, Tumer L, Erten Y, Isitman M, et al. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation. Gene. 2013;527:42\u20137.","journal-title":"Gene"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","volume":"44","author":"A Rolfs","year":"2013","unstructured":"Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, et al. Acute cerebrovascular disease in the young: the stroke in young Fabry patients study. Stroke. 2013;44:340\u20139.","journal-title":"Stroke"},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11739-017-1704-y","volume":"12","author":"R Manna","year":"2017","unstructured":"Manna R, Cauda R, Feriozzi S, Gambaro G, Gasbarrini A, Lacombe D, et al. Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med. 2017;12:1059\u201367.","journal-title":"Intern Emerg Med"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1399-0004.2012.01940.x","volume":"83","author":"C Zizzo","year":"2013","unstructured":"Zizzo C, Colomba P, Albeggiani G, Gallizzi R, Iemolo F, Nuzzo D, et al. Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease. Clin Genet. 2013;83:576\u201381.","journal-title":"Clin Genet"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10528-016-9731-3","volume":"54","author":"C Huzmeli","year":"2016","unstructured":"Huzmeli C, Candan F, Alaygut D, Bagci G, Akkaya L, Bagci B, et al. Prevalence of fabry disease in familial Mediterranean fever patients from central Anatolia of Turkey. Biochem Genet. 2016;54:448\u201356.","journal-title":"Biochem Genet"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","volume":"40","author":"A Livneh","year":"1997","unstructured":"Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879\u201385.","journal-title":"Arthritis Rheum"},{"key":"846_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchromb.2012.09.012","volume":"908","author":"TP Mechtler","year":"2012","unstructured":"Mechtler TP, Metz TF, M\u00fcller HG, Ostermann K, Ratschmann R, De Jesus VR, et al. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;908:9\u201317.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"846_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(11)61266-X","volume":"379","author":"TP Mechtler","year":"2012","unstructured":"Mechtler TP, Stary S, Metz TF, De Jes\u00fas VR, Greber-Platzer S, Pollak A, et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet. 2012;379:335\u201341.","journal-title":"Lancet"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ymgme.2017.06.006","volume":"121","author":"A Nowak","year":"2017","unstructured":"Nowak A, Mechtler T, Kasper DC, Desnick RJ. Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease. Mol Genet Metab. 2017;121:320\u20134.","journal-title":"Mol Genet Metab"},{"key":"846_CR28","first-page":"787","volume":"18","author":"A Dinc","year":"2000","unstructured":"Dinc A, Simsek I, Pay S, Caglar K, Can C. Fabry\u2019s disease mimicking familial Mediterranean fever. Clin Exp Rheumatol. 2000;18:787\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/cge.12135","volume":"83","author":"I Simsek","year":"2013","unstructured":"Simsek I, Yilmaz S, Cinar M, Erdem H, Pay S, et al. Response to Zizzo. Clin Genet. 2013;83:582\u20133.","journal-title":"Clin Genet"},{"key":"846_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12883-015-0513-z","volume":"15","author":"L Fancellu","year":"2015","unstructured":"Fancellu L, Borsini W, Romani I, Pirisi A, Deiana GA, Sechi E, et al. Exploratory screening for Fabry\u2019s disease in young adults with cerebrovascular disorders in northern Sardinia. BMC Neurol. 2015;15:256.","journal-title":"BMC Neurol"},{"key":"846_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jjcc.2022.05.003","volume":"80","author":"T Kubo","year":"2022","unstructured":"Kubo T, Amano M, Takashio S, Okumura T, Yamamoto S, Nabeta T, et al. A retrospective investigation to establish new screening approach for the detection of patients at high risk of fabry disease in male left ventricular hypertrophy patients. J Cardiol. 2022;80:325\u201331.","journal-title":"J Cardiol"},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s10038-019-0633-1","volume":"64","author":"N Nakagawa","year":"2019","unstructured":"Nakagawa N, Sawada J, Sakamoto N, Takeuchi T, Takahashi F, Maruyama JI, et al. High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations. J Hum Genet. 2019;64:891\u20138.","journal-title":"J Hum Genet"},{"key":"846_CR33","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/j.1468-1331.2012.03737.x","volume":"19","author":"H Sarikaya","year":"2012","unstructured":"Sarikaya H, Yilmaz M, Michael N, Miserez AR, Steinmann B, Baumgartner RW. Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA. Eur J Neurol. 2012;19:1421\u20136.","journal-title":"Eur J Neurol"},{"key":"846_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cca.2019.10.045","volume":"501","author":"C Auray-Blais","year":"2020","unstructured":"Auray-Blais C, Lavoie P, Abaoui M, C\u00f4t\u00e9 AM, Boutin M, Akbari A, et al. High-risk screening for Fabry disease in a Canadian cohort of chronic kidney disease patients. Clin Chim Acta. 2020;501:234\u201340.","journal-title":"Clin Chim Acta"},{"key":"846_CR35","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/biom11070951","volume":"11","author":"V Gragnaniello","year":"2021","unstructured":"Gragnaniello V, Burlina AP, Polo G, Giuliani A, Salviati L, Duro G, et al. Newborn screening for Fabry disease in Northeastern Italy: results of five years of experience. Biomolecules. 2021;11:951.","journal-title":"Biomolecules"},{"key":"846_CR36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00431-017-2950-8","volume":"176","author":"C Colon","year":"2017","unstructured":"Colon C, Ortolano S, Melcon-Crespo C, Alvarez JV, Lopez-Suarez OE, Couce ML, et al. Newborn screening for Fabry disease in the north-west of Spain. Eur J Pediatr. 2017;176:1075\u201381.","journal-title":"Eur J Pediatr"},{"key":"846_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2019.100562","volume":"22","author":"T Sawada","year":"2020","unstructured":"Sawada T, Kido J, Yoshida S, Sugawara K, Momosaki K, Inoue T, et al. Newborn screening for Fabry disease in the western region of Japan. Mol Genet Metab Rep. 2020;22: 100562.","journal-title":"Mol Genet Metab Rep"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00846-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00846-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T11:26:47Z","timestamp":1678361207000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00846-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00846-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from the Sheba Medical Center Ethics Committee was obtained. Signed informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual data that require consent for publication are published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}